Final phase 2a results showed that CAN-2409 led to a median overall survival of 24.5 months in immune checkpoint ...

Singaporean biotech Shanton Pharma has reported positive top-line results from a Phase IIb clinical trial of its ...

At Lynnwood-based RAW Aesthetics and Wellness Med Spa, Dr. Bridgette Jeffries believes that mental health begins with looking ...

Protara Therapeutics’ leading candidate is TARA-002, which so far looks like a promising immune-stimulating therapy derived ...

I remember sitting in a dreary examination room talking with the veterinarian. Her patient was my 17-year-old Jack Russell terrier, who was not just certifiably old, but suffering from arthritis and ...

The God’s Gladiators submission fighting team made a powerful impression at the 2025 NAGA Submission Fighting Championships ...

The Hindu World of Women (WoW) Awards 2025, a prestigious annual recognition platform, recognises excellence in 13 distinct ...

The wife of a Hawaii doctor accused of trying to kill her on a hiking trail has filed a petition for a temporary restraining order detailing the alleged attack.

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

The committee based its decision on data showing the subcutaneous formulation of Opdivo was not inferior to the intravenous formulation.

A novel intranasal drug delivery system for brain tumors is advancing clinical trials in India, offering a non-invasive, ...

Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating polyneuropathy as maintenance therapy after stabilization with ...